1. Introduction {#sec1}
===============

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE), is a serious complication frequently occurring in surgical patients. In Japan, perioperative PTE occurs with a prevalence of 3 per 10000 surgeries, and its mortality rate is approximately 15% [@bib1]. Gynecologic surgery has the third highest incidence rate of VTE [@bib1]. Gynecologic patients undergoing malignant pelvic surgery have an elevated risk of VTE, and appropriate prophylaxis can reduce postoperative VTE; some studies have reported that the incidence of postoperative VTE decreased to 5--18% with prophylaxis from 35% without prophylaxis [@bib2], [@bib3]. Preoperative VTE screening may be of use because prophylactic medicine for postoperative VTE is usually not prescribed in patients with benign disease. In general, preoperative VTE should be considered as an indication for anticoagulant treatment before surgery, and an intermittent pneumatic pedal compression device should not be used in patients with DVT.

The plasma D-dimer (DD) test and proximal/distal vein compression ultrasonography (CUS) are frequently used as an easy, preoperative VTE screening method in many countries, including Japan. DD is detectable in patients with VTE as it is a marker of endogenous fibrinolysis, which has a high negative predictive value (NPV). DD is highly sensitive (\>95%) in excluding acute VTE at the cutoff value of 0.5 mg FEU/L, at least in patients with low or intermediate clinical probability [@bib4]. Taira et al. reported that low clinical probability patients with negative DD (\<0.5 mg DDU/ml) may not require additional and costly imaging studies [@bib5]. Although proximal vein CUS is a highly sensitive and specific tool for diagnosing DVT, it is less sensitive to pelvic vein thrombosis and calf vein thrombosis [@bib6]. However, targeted patients for these two examinations are different among each country, region, and hospital because the indication criteria for both examinations are unclear in surgical patients. Besides, although the cutoff value of DD is \< 1.0 μg/mL (latex assay) in our hospital, we have occasionally found that patients with a low preoperative DD level (between 0.6 and 0.9 μg/mL by the latex assay) and no clinical symptoms had VTE detected on imaging examinations.

The objective of this retrospective study was to evaluate the utility of DD and CUS as a preoperative VTE screening method in 380 gynecologic patients in Japan and to establish when and how DD and CUS should be used.

1.1. Patients and methods {#sec1.1}
-------------------------

We retrospectively reviewed 380 gynecologic surgical patients who underwent preoperative VTE screening including the plasma DD test (latex assay) and proximal/distal CUS from March 2014 to February 2015 ([Fig. 1](#fig1){ref-type="fig"}). Approval of the institutional study board was obtained, and data was retrieved from patient case records. All patients underwent laparotomy or laparoscopy. In patients who had high risk of VTE such as swollen legs or advanced cancer, CUS was substituted by or combined with contrast-enhanced computed tomography (CT).

With respect to DD level, patients were divided into three groups: DD level ≤0.5 μg/mL (group A), DD level between 0.6 and 0.9 μg/mL (group B), and DD level ≥ 1.0 μg/mL (group C).

Preoperative risk factors of VTE included 11 items: age ≥66 years, obesity (body mass index ≥ 25 kg/m^2^), hypertension, history of previous VTE, varix, angiitis, leg paralysis, prolonged bed rest, hormone replacement therapy, chemotherapy, and huge intrapelvic tumor (≥10 × 10 cm).

The results are expressed as number (%) or mean ± standard deviation. The statistical difference was determined by the chi-square test. Differences with *P* \< 0.05 were considered significant.

This work has been reported as case series in line with the PROCESS criteria [@bib7].

2. Result {#sec2}
=========

Patient characteristics are shown in [Table 1](#tbl1){ref-type="table"}. Among the 380 patients, 292 underwent laparotomy and 88 underwent laparoscopy. With regard to malignancy, there were 122 cases of cancer, 6 cases of borderline tumors, and 252 cases of benign diseases. Twenty-seven patients had preoperatively detected VTE (15 malignant cases, 1 borderline case, and 11 benign cases) ([Table 1](#tbl1){ref-type="table"}). Ovarian cancer with preoperative VTE (N = 12) included serous adenocarcinoma (5 cases) and clear cell adenocarcinoma (4 cases). Three patients who had benign disease and belonged to group B were diagnosed with VTE before surgery. Among benign patients in group B, there was a significant difference in preoperative VTE occurrence between patients without risk factors (0/68 cases) and those with risk factors (3/54 cases). All 11 patients with benign disease having preoperative VTE had one or more risk factors of eleven items. All preoperative VTE patients were treated by appropriate approach before and after surgeries, and fatal PTE has not occurred in this study.

3. Discussion {#sec3}
=============

PTE is one of the most serious perioperative complications and should be prevented or diagnosed as soon as possible. Therefore, all gynecologic surgical patients should undergo preoperative VTE screening, such as a review of medical and family history, physical examination, and laboratory testing. Frequently used, noninvasive methods of preoperative VTE screening are obtaining the history and performing physical examinations. The Wells score for DVT appears to be the most commonly utilized pretest probability scoring system. Used on its own, it has high NPV for DVT (96%; 87--100%). Furthermore, the Wells score combined with a negative DD test indicates higher NPV for DVT (median value 99%; 96--100%) [@bib8].

In this study, we focused on the preoperative DD test and CUS as a screening approach. The DD test is an invasive measure, but it can be simultaneously checked when a preoperative blood sample is obtained. A previous studies concluded that a DD level of \<0.5 mg/mL by an enzyme-linked immunosorbent assay or a negative SimpliRED assay in conjunction with a low clinical probability may be useful in ruling out DVT, without the need for ultrasound testing [@bib9]. In our study, none of 124 patients with a preoperative DD level of ≤0.5 μg/mL (latex assay) had DVT detected by CUS. This result indicates that patients with asymptomatic VTE or high clinical probability scoring rarely show a DD level of ≤0.5 μg/mL. Therefore, a DD level of ≤0.5 μg/mL (latex assay) can rule out preoperative VTE as it is a screening test with very high reliability.

Patients in group B included 4 preoperative VTE cases (4/149, 2.7%) in our study, and 3 of these had benign diseases. Benign diseases generally have a lower risk of VTE than malignant diseases [@bib10], so preoperative screening for VTE is sometimes omitted in patients with a low clinical probability. However, an intermittent pneumatic compression of lower extremities during surgery may lead to critical PTE if patients have asymptomatic DVT. Currently, the appropriate approach to "benign" and "low DD" patients is not well established. According to the results of our study, the 11 risk factors of VTE may be useful to screen out preoperative patients who need further imaging examination, including CUS. These factors were selected according to guidelines and recent studies [@bib11], [@bib12], [@bib13], [@bib14].

The present study revealed two results with respect to patients with benign disease. First, among benign patients with low preoperative DD levels (0.6--0.9 μg/mL), there was a significant difference in preoperative VTE occurrence between the group without risk factors and that with risk factors. Second, all 11 patients with benign disease having preoperative VTE had one or more risk factors. These two results indicate that even if patients with benign disease had low preoperative DD levels, CUS or contrast-enhanced CT should be performed in the high-risk VTE group in order to assess preoperative VTE and to perform surgeries safely.

There are several limitations to this study. Although proximal/distal leg vein CUS was mainly used as an imaging measure, CUS is less sensitive to pelvic vein thrombosis and calf vein thrombosis [@bib6]. Furthermore, the number of patients was insufficient to identify particular preoperative risk factors of VTE among the 11 risk factors used by statistical analysis.

4. Conclusion {#sec4}
=============

Even in benign cases with low preoperative DD levels (0.6--0.9 μg/mL), an imaging test should be added when the patient has one or more VTE risk factors. Although our report is only a small study, we believe that our suggestion can help to establish the best preoperative screening method for VTE.
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Patients characteristics and results of preoperative VTE screening.

Table 1

  --------------------------------------------------------------------------------------------------------------------------
                                      N = 380              Preoperative VTE (N = 27)                      
  ----------------------------------- -------------------- ---------------------------------------------- ------------------
  **Age (years)**                                          47 (13.45)[a](#tbl1fna){ref-type="table-fn"}   --

  **Body mass index (kg/m**^2^**)**                        23.6 (4.4)[a](#tbl1fna){ref-type="table-fn"}   --

  **Approach**                                                                                            

   Laparotomy                                              292                                            26

   Laparoscopy                                             88                                             1

  **Histological type**                                                                                   

   Benign                                                  252                                            11 (4.4%)

   Border                                                  6                                              1

   Malignant                                               122                                            15 (12.3%)

                                      Cervical cancer      21                                             0

                                      Endometrial cancer   44                                             2 (4.5%)

                                      Ovarian cancer       46                                             12 (26.1%)

                                      Peritoneal cancer    5                                              1

                                      Others               7                                              0

  **Plasma D-dimer level (μg/mL)**                                                                        

   ≤0.5                                                    124                                            0

   0.6--0.9                                                149                                            4 (2.7%)

   ≥1.0                                                    97\                                            23 (23.7%)\
                                                           Number\                                        Number (percent)
  --------------------------------------------------------------------------------------------------------------------------

Mean (SD).
